ArticleCancer science2020
Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.
Lingxu Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it